These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 7557850)
21. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response. Chu CM; Sheen IS; Liaw YF Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075 [TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays. Lunel F; Cresta P; Vitour D; Payan C; Dumont B; Frangeul L; Reboul D; Brault C; Piette JC; Huraux JM Hepatology; 1999 Feb; 29(2):528-35. PubMed ID: 9918931 [TBL] [Abstract][Full Text] [Related]
23. A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C. Chayama K; Tsubota A; Kobayashi M; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Murashima N; Ikeda K; Kumada H Hepatology; 1996 May; 23(5):953-7. PubMed ID: 8621174 [TBL] [Abstract][Full Text] [Related]
24. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta. Kobayashi Y; Watanabe S; Konishi M; Yokoi M; Kakehashi R; Kaito M; Kondo M; Hayashi Y; Jomori T; Suzuki S Hepatology; 1993 Dec; 18(6):1319-25. PubMed ID: 8244255 [TBL] [Abstract][Full Text] [Related]
25. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction. Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145 [TBL] [Abstract][Full Text] [Related]
26. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels. Yamamoto C; Enomoto N; Kurosaki M; Yu SH; Tazawa J; Izumi N; Marumo F; Sato C Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006 [TBL] [Abstract][Full Text] [Related]
27. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865 [TBL] [Abstract][Full Text] [Related]
28. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. McGuinness PH; Bishop GA; Painter DM; Chan R; McCaughan GW Hepatology; 1996 Apr; 23(4):676-87. PubMed ID: 8666317 [TBL] [Abstract][Full Text] [Related]
29. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715 [TBL] [Abstract][Full Text] [Related]
30. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver]. Hige S Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730 [TBL] [Abstract][Full Text] [Related]
31. [Investigation of the relationship between hepatitis c virus (HCV) genotypes with HCV-RNA and alanine aminotransferase levels in chronic hepatitis c patients]. Küçköztaş MF; Ozgünes N; Yazici S Mikrobiyol Bul; 2010 Jan; 44(1):111-5. PubMed ID: 20455406 [TBL] [Abstract][Full Text] [Related]
32. [Serum levels of HCV-RNA determined by branched DNA (bDNA) probe assay in chronic hepatitis C: method and clinical significance on interferon (IFN) therapy]. Osada T; Iwabuchi S; Takatori M; Murayama M; Iino S Nihon Rinsho; 1994 Jul; 52(7):1747-53. PubMed ID: 7521414 [TBL] [Abstract][Full Text] [Related]
33. [Predicting factors for the response to interferon therapy against hepatitis C virus infection: HCV genotyping]. Yoshioka K; Kakumu S Rinsho Byori; 1994 Oct; 42(10):1010-4. PubMed ID: 7527870 [TBL] [Abstract][Full Text] [Related]
34. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Zeuzem S; Lee JH; Franke A; Rüster B; Prümmer O; Herrmann G; Roth WK Hepatology; 1998 Apr; 27(4):1149-56. PubMed ID: 9537457 [TBL] [Abstract][Full Text] [Related]
35. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C. Orito E; Mizokami M; Nakano T; Terashima H; Nojiri O; Sakakibara K; Mizuno M; Ogino M; Nakamura M; Matsumoto Y J Med Virol; 1994 Dec; 44(4):410-4. PubMed ID: 7897373 [TBL] [Abstract][Full Text] [Related]
36. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C. Mizokami M; Orito E; Gibo Y; Suzuki K; Ohba K; Ohno T; Lau JY Liver; 1996 Feb; 16(1):23-7. PubMed ID: 8868074 [TBL] [Abstract][Full Text] [Related]
37. Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission. Papatheodoridis GV; Katsoulidou A; Touloumi G; Delladetsima JK; Hatzakis A; Tassopoulos NC Eur J Gastroenterol Hepatol; 1996 May; 8(5):469-75. PubMed ID: 8804876 [TBL] [Abstract][Full Text] [Related]
38. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy. Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506 [TBL] [Abstract][Full Text] [Related]
39. Spontaneous loss of hepatitis C virus RNA from serum is associated with genotype 1 and younger age at exposure. Rolfe KJ; Curran MD; Alexander GJ; Woodall T; Andrews N; Harris HE J Med Virol; 2011 Aug; 83(8):1338-44. PubMed ID: 21618556 [TBL] [Abstract][Full Text] [Related]
40. Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients. Manesis EK; Papaioannou C; Gioustozi A; Kafiri G; Koskinas J; Hadziyannis SJ Hepatology; 1997 Sep; 26(3):734-9. PubMed ID: 9303505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]